Reasonable price for Velpatasvir Manufacturer - Elagolix 834153-87-6 – CPF

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

Our business has been focusing on brand strategy. Customers' pleasure is our best advertising. We also offer OEM company for Amlodipine And Hydrochlorothiazide Tablets, Amiloride And Hydrochlorothiazide, Hydrochlorothiazide High, For even more inquires remember to do not hesitate to get in touch with us. Thank you - Your support continuously inspires us.
Reasonable price for Velpatasvir Manufacturer - Elagolix 834153-87-6 – CPF Detail:

This medication is used by women to help relieve moderate to severe pain due to a condition called endometriosis.
May Treat: Endometriosis
Brand Names: Orilissa
Drug Class: LHRH (GnRH) Antagonists
Availability: Prescription Required
Pregnancy: Avoid use during pregnancy
Lactation: Consult a doctor before using

Elagolix is an orally bioavailable, second-generation, non-peptide based, small molecule compound and selective gonadotropin-releasing hormone (GnRH; LHRH) receptor antagonist, with potential hormone production inhibitory activity. Upon oral administration, elagolix competes with GnRH for receptor binding and inhibits GnRH receptor signaling in the anterior pituitary gland. This inhibits the secretion of luteinizing hormone (LH) and follicle stimulating hormone (FSH). In males, the inhibition of LH secretion prevents the release of testosterone. In women, inhibition of FSH and LH prevents the production of estrogen by the ovaries. Inhibition of GnRH signaling may treat or prevent symptoms of sex hormone-dependent disease states.

Elagolix is an oral, nonsteroidal gonadotropin releasing hormone (GnRH) antagonist that decreases estrogen production and is used to treat painful forms of endometriosis in women. Elagolix therapy is associated with a low rate of serum enzyme elevations during therapy and has yet to be linked to instances of clinically apparent liver injury.

Elagolix has been used in trials studying the basic science and treatment of Endometriosis, Folliculogenesis, Uterine Fibroids, Heavy Uterine Bleeding, and Heavy Menstrual Bleeding. As of 24 July 2018, however, the U.S. Food and Drug Administration (FDA) approved AbbVie’s elagolix under the brand name Orilissa as the first and only oral gonadotropin-releasing hormone (GnRH) antagonist specifically developed for women with moderate to severe endometriosis pain. It has been determined that endometriosis is one of the most common gynecologic disorders in the United States. In particular, estimates suggest that one in ten women of reproductive age is affected by endometriosis and experience debilitating pain symptoms. Moreover, women who are affected by this condition can suffer for up to six to ten years and visit multiple physicians before receiving a proper diagnosis. Subsequently, as Orilissa (elagolix) was approved by the FDA under priority review, this expedited new approval gives healthcare professionals another valuable option for treating the potentially unmet needs of women who are affected by endometriosis, depending on their specific type and severity of endometriosis pain.

Chemical structure

dsfs
2018 GMP-2
原料药GMP证书201811(captopril ,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

OUR STRENGTH

Quality management1

Proposal 18 Quality Consistency Evaluation projects which have approved 4, and 6 projects are under approving.

Quality management2

Advanced international quality management system has laid solid foundation for sales.

Quality management3

Quality supervision runs through the whole life cycle of the product to ensure the quality and therapeutic effect. 

Quality management4

Professional Regulatory Affairs team supports the quality demands during the application and registration.


VIEW MORE


VIEW MORE

International cooperation
International cooperation
Domestic cooperation
Domestic cooperation


Product detail pictures:

Reasonable price for Velpatasvir Manufacturer - Elagolix 834153-87-6  – CPF detail pictures


Related Product Guide:

Every single member from our higher effectiveness product sales staff values customers' requires and organization communication for Reasonable price for Velpatasvir Manufacturer - Elagolix 834153-87-6 – CPF , The product will supply to all over the world, such as: Armenia, Bangladesh, Norwegian, Our aim is to help customers realize their goals. We are making great efforts to achieve this win-win situation and sincerely welcome you to join us. In a word, when you choose us, you choose a perfect life. Welcome to visit our factory and welcome your order! For further inquiries, please do not hesitate to contact us.
  • This supplier stick to the principle of "Quality first, Honesty as base", it is absolutely to be trust.
    5 Stars By Jean from Russia - 2018.12.10 19:03
    The quality of the products is very good, especially in the details, can be seen that the company work actively to satisfy customer's interest, a nice supplier.
    5 Stars By Adam from Jordan - 2018.09.16 11:31
    Write your message here and send it to us